Investors are targeting Calix, Inc. in a federal class action lawsuit alleging the company issued false and misleading statements regarding its financial health. The complaint centers on claims that the firm obscured margin pressures caused by volatile memory module prices between January and April of 2026.
Shareholders who purchased Zoetis Inc. stock between January 14, 2025, and May 6, 2026, face a critical window to join a class action lawsuit. The Schall Law Firm is currently organizing investors to seek damages following allegations that the company misled the market regarding its core veterinary product performance.
A class action lawsuit has been filed against Zoetis Inc., accusing the pharmaceutical company of disseminating false and misleading information to shareholders between January 14, 2025, and May 6, 2026. The litigation centers on claims that the firm obscured significant performance hurdles across its key product lines.
At the 5G-A Experience Monetization forum in Shanghai, industry leaders unveiled a high-speed rail connectivity package and new agent-centric network architectures. Scheduled for commercial launch this August, the initiatives aim to bridge the gap between terminal capabilities and network infrastructure to foster large-scale 5G-A deployment across China.
Investors who held SES AI Corporation stock between January 29, 2025, and March 4, 2026, are being urged to join a class action lawsuit. The litigation alleges that the company violated the Securities Exchange Act by issuing materially misleading statements regarding its financial health and operational practices.
Shareholders who purchased Embecta Corp. stock between November 25, 2025, and May 4, 2026, are being urged to join a pending class action lawsuit. The Schall Law Firm alleges the company misled investors regarding its fiscal guidance despite knowing of significant performance headwinds in the pen needle market.
In Budapest, AUTOCRYPT showcased its new Digital Key Self-Testing Toolkit, designed to allow manufacturers to validate automotive security features before they hit the assembly line. The demonstration at the Car Connectivity Consortium meeting focused on streamlining the integration of software-defined vehicle interfaces.
Melbourne-based Avecho Biotechnology will continue its pivotal Phase III insomnia trial after an independent Data Monitoring Board confirmed the study met key interim criteria. The review of 244 participants showed no serious adverse events, clearing the path for the company to enroll the full cohort of 519 patients.
Investors who purchased Black Rock Coffee Bar, Inc. securities between September 12, 2025, and May 12, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled the market regarding the impact of store cannibalization on its financial performance during that period.
Investors who purchased BitGo Holdings stock following the company's January 2026 initial public offering are now being recruited for a class action lawsuit. The Schall Law Firm alleges that BitGo misled shareholders by downplaying the financial risks associated with the volatility of digital asset markets during its market debut.
Investors who purchased Futu Holdings Limited securities between May 24, 2023, and May 27, 2026, face a critical deadline to join a class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging that the company misled shareholders regarding its compliance with Chinese regulatory mandates.
At Intersolar Europe 2026 in Munich, Sermatec unveiled a suite of high-density energy storage systems and digital management tools. The company used the exhibition to sign multiple international partnership agreements, signaling an aggressive push to scale its utility-scale and commercial storage infrastructure across the European market.
Investors who purchased Peabody Energy Corporation securities between October 14, 2024, and May 4, 2026, face a critical window to join a class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging the company misled the market regarding operational stability and growth projections at its Centurion mine site.
Investors who purchased Futu Holdings shares between May 24, 2023, and May 27, 2026, are being urged to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centered on claims that the company misled shareholders regarding its compliance with Chinese regulatory authorities.
Strategic Value Partners has bolstered its European investment team with the hire of Jean-Baptiste de Boissieu as Managing Director. Based in the firm’s London office, he will spearhead efforts in liquid and private credit, alongside restructuring and special situations, as the global firm seeks to expand its footprint across Europe.
Investors who purchased Phreesia, Inc. stock between May 8, 2025, and March 30, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled the market regarding its fiscal year 2027 growth projections and the stability of its pharmaceutical marketing commitments.
In Jiaxing, Zhejiang Province, Shanghai-based WhalesBot has opened its second AI+Robotics Exploration Center, signaling a strategic shift in Chinese tech education. The facility prioritizes physical interaction—coding, drone flight, and sensor debugging—over passive screen time, aiming to ground artificial intelligence concepts in real-world experimentation for students aged 3 to 22.
Investors who purchased Sportradar Group AG shares between November 7, 2024, and April 21, 2026, are being urged to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centered on claims that the company misled shareholders regarding its internal compliance and vetting standards.
Shares of Sportradar Group AG plummeted 22 percent following a damaging report from Muddy Waters Research that accused the data provider of intentionally facilitating operations for illegal gambling markets. The Schall Law Firm has now launched an investigation into whether the company misled shareholders regarding its business practices and regulatory compliance.
Investors who purchased Calix, Inc. securities between January 28 and April 21, 2026, face a critical window to join a pending class action lawsuit. The Schall Law Firm is currently seeking plaintiffs to challenge the company over alleged violations of the Securities Exchange Act following claims of misleading financial disclosures.
Investors who held Badger Meter, Inc. securities between April 18, 2024, and April 16, 2026, face a critical deadline to join a class action lawsuit. The Schall Law Firm is seeking participants to allege that the company misled the market regarding its financial health and revenue recognition practices.
Investors who acquired AeroVironment, Inc. securities between June 25, 2025, and March 10, 2026, face a critical deadline to join a pending class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging the company misled the market regarding its competitive standing within the U.S. Space Force SCAR program.
Investors who purchased GeneDx Holdings Corp. securities between April 16, 2025, and May 4, 2026, are being urged to join a class action lawsuit led by The Schall Law Firm. The litigation centers on claims that the company misled the market regarding its financial health during the specified period.
Between June 22 and June 26, 2026, Telefonaktiebolaget LM Ericsson acquired 6,116,402 of its own Class B shares. The transactions, executed on Nasdaq Stockholm via Goldman Sachs Bank Europe SE, represent a total investment of approximately 675.7 million SEK as the company continues its multi-billion crown capital return program.
Strategic Value Partners has recruited Jean-Baptiste de Boissieu as a Managing Director to bolster its European investment operations. Based in the firm’s London office, de Boissieu will focus on expanding the firm's reach in liquid and private credit, alongside complex restructuring and special situations across the European market.
Investors who purchased SES AI Corporation securities between January 29, 2025, and March 4, 2026, are being sought for a class action lawsuit. The Schall Law Firm alleges that the company violated the Securities Exchange Act by providing false and misleading information to the market regarding its business deals.
Shareholders who acquired POET Technologies stock between April 1 and April 27, 2026, face potential financial losses following allegations of federal securities law violations. The Schall Law Firm is now organizing a class action lawsuit against the company, centered on claims of misleading market disclosures regarding tax status and executive conduct.
The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending upadacitinib for treating adults and adolescents with severe alopecia areata. This regulatory milestone brings the JAK inhibitor closer to becoming a new therapeutic option for patients struggling with the unpredictable autoimmune condition.
The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending the approval of upadacitinib for treating severe alopecia areata in adults and adolescents. If finalized by the European Commission, the drug would provide a new systemic option for patients facing the unpredictable autoimmune condition.
Investors who purchased FS KKR Capital Corp. securities between May 8, 2024, and February 25, 2026, face a looming July 3 deadline to join a class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging the company misled shareholders regarding its portfolio valuation and dividend sustainability.
